Here are 5 things individuals should know about the powerful impact of blood donation and the benefits becoming a donor can ...

Takeda has reported positive results from a phase 3 trial of its experimental therapy TAK-755 for ultra-rare disease congenital thrombotic thrombocytopenic purpura (cTTP), setting up regulatory ...

In 2002, J Dilla had been diagnosed with thrombotic thrombocytopenic purpura (TTP), an incurable disease of the blood, while also battling lupus, which had been diagnosed a year previously.

The European Commission has approved Sanofi’s Cablivi, the first treatment for patients with the rare blood-clotting disorder, acquired thrombotic thrombocytopenic purpura (aTTP), which is also ...

Narsoplimab is under clinical development by Omeros and currently in Phase II for Coronavirus Disease 2019 (COVID-19).